Syngene reported Total revenue for Q4 FY23 of ₹994 Crore, up from ₹759 Crore year on year, a growth of 31%.While, consolidated Net Profit of ₹179 Crore, up 21% from ₹147 Crore in the same quarter of the previous year. The Earnings per Share is ₹4.43, up 21% from ₹3.67 in the same quarter of the previous year.
Syngene reported 21 percent rise in its Q4FY23 net profit
Related Post
- SMC Global Securities Ltd Q2FY25; 15% rise in Profits
SMC Global Securities Ltd (SMC) is a well-diversified financial service company in India & Abroad,…
-
Natco Pharma Ltd Q2FY25; 83% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged…
-
Muthoot Finance Ltd Q2FY25; 26% rise in Profits
Muthoot Finance is NBFC engaged in the business of providing gold loans. The company predominately…